Cytomegalovirus Infections Clinical Trials

164 clinical trials for Cytomegalovirus Infections across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• R-MVST Cells for Treatment of Viral Infections in Children and Young Adults — RECRUITING · PHASE1
• CMV-CMI in csCMVi After HSCT — RECRUITING
• Anti-viral T-cell Therapy by Gamma Capture — RECRUITING · PHASE1
• Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients — RECRUITING
• Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients — RECRUITING · PHASE3
• R-MVST Cells for Treatment of Viral Infections — RECRUITING · PHASE1
• Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection — RECRUITING
• Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals — RECRUITING
• Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients — RECRUITING · PHASE2
• Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. — RECRUITING · PHASE4
• Breakthrough CMV Lung Transplant -Multicentre — RECRUITING
• Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT — RECRUITING · NA
• T Cell Therapy of Opportunistic Cytomegalovirus Infection — RECRUITING · PHASE1
• Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity — RECRUITING · PHASE1
• Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) — RECRUITING · PHASE2
• Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis — RECRUITING · NA
• Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients — RECRUITING · PHASE4
• A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® — RECRUITING · PHASE2
• ATG Individualized Dosing Model in URD-PBSCT. — RECRUITING · PHASE2
• Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) — RECRUITING · NA
• Evaluation of CMV/EBV-CMI in Haploid HSCT — RECRUITING
• Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study — RECRUITING
• Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study — ACTIVE_NOT_RECRUITING
• A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults — COMPLETED · PHASE1
• Cytomegalovirus Infection in Patients With HIV-1 Infection — COMPLETED · PHASE3
• Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV — TERMINATED · PHASE1
• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) — COMPLETED · PHASE2
• Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients — ACTIVE_NOT_RECRUITING · PHASE4
• Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation — ACTIVE_NOT_RECRUITING
• AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients — COMPLETED
• Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone — NOT_YET_RECRUITING · PHASE3
• HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR — NOT_YET_RECRUITING
• Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. — TERMINATED · PHASE2
• A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants — COMPLETED · PHASE1
• Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia — COMPLETED · PHASE2
• Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation — COMPLETED
• Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus — COMPLETED · PHASE1
• TETRAVI Expanded Access Program — OTHER
• Letermovir Use in Heart Transplant Recipients — COMPLETED · PHASE4
• Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis — COMPLETED · PHASE4
• Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation — ACTIVE_NOT_RECRUITING · PHASE1
• HCMV Breakthrough Infections During Letermovir Prophylaxis — OTHER · NA
• Non Primary HCMV Infection: Natural History and Immune Response — ACTIVE_NOT_RECRUITING
• Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells — TERMINATED · PHASE1
• Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation — COMPLETED · PHASE3
• Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis — OTHER
• Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — TERMINATED · PHASE2
• Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — COMPLETED · PHASE2
• Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, — COMPLETED

Refine this search